Keyphrases
Broadly Neutralizing Antibodies
100%
High Potency
100%
HIV-1 Treatment
100%
HIV-1 Infection
50%
Human Immunodeficiency Virus Type 1 (HIV-1)
25%
Infectious Diseases
25%
Anti-HIV-1
25%
Technological Progress
25%
HIV Antibodies
25%
Therapeutic Modalities
25%
Serum Half-life
25%
Immunology and Microbiology
Monospecific Antibody
100%
Human Immunodeficiency Virus 1
100%
Neutralizing Antibody
100%
Plasma Half Life
20%
Infectious Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Neutralizing Antibody
100%
Human Immunodeficiency Virus 1 Infection
40%
Infection
20%
Anti-Human Immunodeficiency Virus
20%